{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:48:01Z","timestamp":1791913681805,"version":"4.3.4"},"reference-count":89,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.canrad.2026.104859","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T19:19:47Z","timestamp":1786562387000},"page":"104859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential diagnosis of imaging alterations after stereotactic radiotherapy of brain metastases: A narrative review"],"prefix":"10.1016","volume":"30","author":[{"given":"Lara","family":"Caglayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Sempels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieselotte","family":"Lauwens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Daisne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0450","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0455","first-page":"vdaa015","article-title":"Medical management of brain metastases","volume":"2","author":"Lauko","year":"2020","journal-title":"Neurooncol Adv"},{"issue":"6","key":"10.1016\/j.canrad.2026.104859_bib0460","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/neuonc\/noaa285","article-title":"The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis","volume":"23","author":"Kuksis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2026.104859_bib0465","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","article-title":"Brain metastases","volume":"5","author":"Achrol","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10.1016\/j.canrad.2026.104859_bib0470","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2026.104859_bib0475","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases","volume":"17","author":"Suh","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2026.104859_bib0480","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00066-020-01603-1","article-title":"Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO\/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery","volume":"196","author":"Guckenberger","year":"2020","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0485","first-page":"10","article-title":"Doses, fractionations, constraints for stereotactic radiotherapy","volume":"27","author":"Borghesi","year":"2022","journal-title":"Rep Pract Oncol Radiother"},{"issue":"9","key":"10.1016\/j.canrad.2026.104859_bib0490","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/cncr.26515","article-title":"A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases","volume":"118","author":"Tsao","year":"2012","journal-title":"Cancer"},{"issue":"6\u20137","key":"10.1016\/j.canrad.2026.104859_bib0495","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.canrad.2024.07.014","article-title":"Diagnosis and management of brain radiation necrosis","volume":"28","author":"Bourbonne","year":"2024","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2026.104859_bib0500","doi-asserted-by":"crossref","first-page":"104765","DOI":"10.1016\/j.canrad.2025.104765","article-title":"Radiotherapy for brain metastases: 2025 update","volume":"29","author":"Antoni","year":"2025","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2026.104859_bib0505","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/j.wneu.2020.10.124","article-title":"Stereotactic radiosurgery results for patients with 5\u201310 versus 11\u201320 brain metastases: a retrospective cohort study combining 2 databases totaling 2,319 patients","volume":"146","author":"Yamamoto","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.canrad.2026.104859_bib0510","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1748-717X-6-48","article-title":"Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis","volume":"6","author":"Minniti","year":"2011","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2026.104859_bib0515","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ijrobp.2009.06.006","article-title":"Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery","volume":"77","author":"Blonigen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2026.104859_bib0520","first-page":"70","article-title":"The individual risk of symptomatic radionecrosis after brain metastasis radiosurgery is predicted by a continuous function of the V12 Gy","volume":"27","author":"Daisne","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2026.104859_bib0525","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/mrm.26546","article-title":"Understanding the continuum of radionecrosis and vascular disorders in the brain following gamma knife irradiation: an MRI study","volume":"78","author":"Constanzo","year":"2017","journal-title":"Magn Reson Med"},{"issue":"1 Suppl","key":"10.1016\/j.canrad.2026.104859_bib0530","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/neuonc\/noad188","article-title":"The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases","volume":"26","author":"Mayo","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2026.104859_bib0535","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11912-019-0818-y","article-title":"Cerebral radiation necrosis: incidence, pathogenesis, diagnostic challenges, and future opportunities","volume":"21","author":"Ali","year":"2019","journal-title":"Curr Oncol Rep"},{"issue":"8","key":"10.1016\/j.canrad.2026.104859_bib0540","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.canrad.2016.07.098","article-title":"Techniques d\u2019imagerie utilis\u00e9es dans le diagnostic diff\u00e9rentiel entre radion\u00e9crose c\u00e9r\u00e9brale et rechute tumorale apr\u00e8s irradiation en conditions st\u00e9r\u00e9otaxiques de m\u00e9tastases c\u00e9r\u00e9brales\u00a0: revue de la litt\u00e9rature","volume":"20","author":"Menoux","year":"2016","journal-title":"Cancer Radiother"},{"issue":"3","key":"10.1016\/j.canrad.2026.104859_bib0545","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2013.05.015","article-title":"Challenges with the diagnosis and treatment of cerebral radiation necrosis","volume":"87","author":"Chao","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0550","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11060-012-0881-9","article-title":"Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery","volume":"109","author":"Stockham","year":"2012","journal-title":"J Neurooncol"},{"issue":"7","key":"10.1016\/j.canrad.2026.104859_bib0555","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.3390\/ijms150711832","article-title":"The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence","volume":"15","author":"Parvez","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.canrad.2026.104859_bib0560","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13014-023-02385-3","article-title":"Histopathologically confirmed radiation-induced damage of the brain\u2013an in-depth analysis of radiation parameters and spatio-temporal occurrence","volume":"18","author":"Kossmann","year":"2023","journal-title":"Radiat Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2026.104859_bib0565","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00066-022-01994-3","article-title":"DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis","volume":"198","author":"Bernhardt","year":"2022","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"10.1016\/j.canrad.2026.104859_bib0570","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/ecp.11.1","article-title":"Corticosteroids in brain cancer patients: benefits and pitfalls","volume":"4","author":"Dietrich","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.canrad.2026.104859_bib0575","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1227\/NEU.0b013e3181fa775b","article-title":"A systematic review of the literature on the effects of dexamethasone on the brain from in vivo human-based studies: implications for physiological brain imaging of patients with intracranial tumors","volume":"67","author":"Kotsarini","year":"2010","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.canrad.2026.104859_bib0580","first-page":"331","article-title":"Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: a role for vascular endothelial growth factor","volume":"162","author":"Nordal","year":"2004","journal-title":"Radiat Res"},{"issue":"5","key":"10.1016\/j.canrad.2026.104859_bib0585","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.canrad.2026.104859_bib0590","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12885-021-07889-3","article-title":"Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review and meta-analysis","volume":"21","author":"Khan","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2026.104859_bib0595","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u00a0\u2013\u00a0a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res Integr Peer Rev"},{"key":"10.1016\/j.canrad.2026.104859_bib0600","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.canrad.2026.104859_bib0605","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11060-017-2545-2","article-title":"Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology","volume":"134","author":"Detsky","year":"2017","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0610","first-page":"vdac179","article-title":"Growth dynamics of brain metastases differentiate radiation necrosis from recurrence","volume":"5","author":"Oca\u00f1a-Tienda","year":"2023","journal-title":"Neurooncol Adv"},{"issue":"3","key":"10.1016\/j.canrad.2026.104859_bib0615","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clon.2016.09.021","article-title":"Characterisation of lesions after stereotactic radiosurgery for brain metastases: impact of delayed contrast magnetic resonance imaging","volume":"29","author":"Wagner","year":"2017","journal-title":"Clin Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2026.104859_bib0620","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3174\/ajnr.A5643","article-title":"Postcontrast T1 mapping for differential diagnosis of recurrence and radionecrosis after gamma knife radiosurgery for brain metastasis","volume":"39","author":"Wang","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1016\/j.canrad.2026.104859_bib0625","doi-asserted-by":"crossref","first-page":"100424","DOI":"10.1016\/j.esmoop.2022.100424","article-title":"MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapy","volume":"7","author":"Bodensohn","year":"2022","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.canrad.2026.104859_bib0630","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/neuonc\/nou230","article-title":"Delayed contrast extravasation MRI: a new paradigm in neuro-oncology","volume":"17","author":"Zach","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2026.104859_bib0635","doi-asserted-by":"crossref","first-page":"e1134","DOI":"10.1016\/j.wneu.2020.11.114","article-title":"The use of treatment response assessment maps in discriminating between radiation effect and persistent tumoral lesion in metastatic brain tumors treated with gamma knife radiosurgery","volume":"146","author":"Peker","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.canrad.2026.104859_bib0640","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3174\/ajnr.A8431","article-title":"Gadolinium-enhanced T2 FLAIR is an imaging biomarker of radiation necrosis and tumor progression in patients with brain metastases","volume":"46","author":"Heyn","year":"2025","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.canrad.2026.104859_bib0645","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.canrad.2017.03.003","volume":"21","author":"Menoux","year":"2017","journal-title":"Cancer Radiother"},{"issue":"8","key":"10.1016\/j.canrad.2026.104859_bib0650","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/j.crad.2022.05.005","article-title":"Susceptibility-weighted imaging cannot distinguish radionecrosis from recurrence in brain metastases after radiotherapy: a comparison with high-grade gliomas","volume":"77","author":"Qin","year":"2022","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.canrad.2026.104859_bib0655","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1148\/radiology.161.2.3763909","article-title":"MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders","volume":"161","author":"Le Bihan","year":"1986","journal-title":"Radiology"},{"key":"10.1016\/j.canrad.2026.104859_bib0660","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.5114\/pjr.2022.116167","article-title":"Intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) of the major salivary glands: an assessment of the optimal number and combination of b-values","volume":"87","author":"Kimura","year":"2022","journal-title":"Pol J Radiol"},{"issue":"11","key":"10.1016\/j.canrad.2026.104859_bib0665","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3174\/ajnr.A3995","article-title":"Utility of intravoxel incoherent motion MR imaging for distinguishing recurrent metastatic tumor from treatment effect following gamma knife radiosurgery: initial experience","volume":"35","author":"Kim","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.canrad.2026.104859_bib0670","doi-asserted-by":"crossref","first-page":"e903","DOI":"10.1016\/j.wneu.2019.11.037","article-title":"Pathologic correlation of cellular imaging using apparent diffusion coefficient quantification in patients with brain metastases after gamma knife radiosurgery","volume":"134","author":"Borghei-Razavi","year":"2020","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0675","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/08465371221115341","article-title":"Diagnostic accuracy of centrally restricted diffusion sign in cerebral metastatic disease: differentiating radiation necrosis from tumor recurrence","volume":"74","author":"Puac-Polanco","year":"2023","journal-title":"Can Assoc Radiol J"},{"issue":"7","key":"10.1016\/j.canrad.2026.104859_bib0680","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11547-018-0866-7","article-title":"Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2","volume":"123","author":"Muto","year":"2018","journal-title":"Radiol Med"},{"issue":"5","key":"10.1016\/j.canrad.2026.104859_bib0685","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3174\/ajnr.A7501","article-title":"DSC perfusion MRI-derived fractional tumor burden and relative CBV differentiate tumor progression and radiation necrosis in brain metastases treated with stereotactic radiosurgery","volume":"43","author":"Kuo","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"10.1016\/j.canrad.2026.104859_bib0690","doi-asserted-by":"crossref","first-page":"758e1","DOI":"10.1016\/j.crad.2018.04.006","article-title":"Absolute CBV for the differentiation of recurrence and radionecrosis of brain metastases after gamma knife radiotherapy: a comparison with relative CBV","volume":"73","author":"Wang","year":"2018","journal-title":"Clin Radiol"},{"key":"10.1016\/j.canrad.2026.104859_bib0695","doi-asserted-by":"crossref","first-page":"823731","DOI":"10.3389\/fneur.2022.823731","article-title":"perfusion for the differentiation of recurrence and radionecrosis in hypoperfusion and hyperperfusion brain metastases after gamma knife radiosurgery","volume":"13","author":"Yunqi","year":"2022","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104859_bib0700","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1227\/neu.0000000000002228","article-title":"Distinguishing brain metastasis progression from radiation effects after stereotactic radiosurgery using longitudinal GRASP dynamic contrast-enhanced MRI","volume":"92","author":"Lee","year":"2023","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.canrad.2026.104859_bib0705","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/brainsci14040321","article-title":"Evaluating the efficacy of perfusion MRI and conventional MRI in distinguishing recurrent cerebral metastasis from brain radiation necrosis","volume":"14","author":"Schack","year":"2024","journal-title":"Brain Sci"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0710","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/jmre.1999.1956","article-title":"A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST)","volume":"143","author":"Ward","year":"2000","journal-title":"J Magn Reson"},{"issue":"6","key":"10.1016\/j.canrad.2026.104859_bib0715","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/jmri.28440","article-title":"Chemical exchange saturation transfer MRI for differentiating radiation necrosis from tumor progression in brain metastasis\u00a0\u2013\u00a0application in a clinical setting","volume":"57","author":"Mehrabian","year":"2023","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0720","first-page":"vdae132","article-title":"Is pulsed saturation transfer sufficient for differentiating radiation necrosis from tumor progression in brain metastases?","volume":"6","author":"Chan","year":"2024","journal-title":"Neurooncol Adv"},{"issue":"8","key":"10.1016\/j.canrad.2026.104859_bib0725","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3174\/ajnr.A5252","article-title":"Differentiation between treatment-induced necrosis and recurrent tumors in patients with metastatic brain tumors: comparison among (11C)-methionine PET, FDG-PET, MR permeability imaging, and MRI-ADC\u2013preliminary results","volume":"38","author":"Tomura","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0730","first-page":"vdz010","article-title":"Current status of PET imaging in neuro-oncology","volume":"1","author":"Galldiks","year":"2019","journal-title":"Neurooncol Adv"},{"issue":"3","key":"10.1016\/j.canrad.2026.104859_bib0735","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2967\/jnumed.107.047787","article-title":"Recommendations on the use of (18F)-FDG PET in oncology","volume":"49","author":"Fletcher","year":"2008","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1016\/j.canrad.2026.104859_bib0740","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/RLU.0000000000004305","article-title":"Delayed (18F)-FDG PET imaging increases diagnostic performance and reproducibility to differentiate recurrence of brain metastases from radionecrosis","volume":"47","author":"Otman","year":"2022","journal-title":"Clin Nucl Med"},{"issue":"18","key":"10.1016\/j.canrad.2026.104859_bib0745","doi-asserted-by":"crossref","first-page":"e37789","DOI":"10.1097\/MD.0000000000037789","article-title":"Narrow interval dual phase (18F)-FDG PET\/CT: a practical approach for distinguishing tumor recurrence from radiation necrosis in brain metastasis","volume":"103","author":"Aggarwal","year":"2024","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.canrad.2026.104859_bib0750","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/neuonc\/now058","article-title":"Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas","volume":"18","author":"Albert","year":"2016","journal-title":"Neuro Oncol"},{"issue":"9","key":"10.1016\/j.canrad.2026.104859_bib0755","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2967\/jnumed.112.103325","article-title":"Role of O-(2-[18F]-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis","volume":"53","author":"Galldiks","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.canrad.2026.104859_bib0760","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13014-016-0713-8","article-title":"Suspected recurrence of brain metastases after focused high dose radiotherapy: can (18F)-FET PET overcome diagnostic uncertainties?","volume":"11","author":"Romagna","year":"2016","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2026.104859_bib0765","first-page":"281","article-title":"Dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy","volume":"19","author":"Ceccon","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2026.104859_bib0770","first-page":"100583","article-title":"Dynamic 18F-FET PET\/CT to differentiate recurrent primary brain tumor and brain metastases from radiation necrosis after single-session robotic radiosurgery","volume":"32","author":"Lim","year":"2022","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.canrad.2026.104859_bib0775","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12885-017-3702-x","article-title":"Prospective study of (11C)-methionine PET for distinguishing between recurrent brain metastases and radiation necrosis: limitations of diagnostic accuracy and long-term results of salvage treatment","volume":"17","author":"Yomo","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2026.104859_bib0780","doi-asserted-by":"crossref","DOI":"10.1177\/1536012120968669","article-title":"(11C)-Methionine and [11C]PBR28 as PET imaging tracers to differentiate metastatic tumor recurrence or radiation necrosis","volume":"19","author":"Tran","year":"2020","journal-title":"Mol Imaging"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0785","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2967\/jnumed.113.121418","article-title":"(18F)-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment","volume":"55","author":"Lizarraga","year":"2014","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0790","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00259-014-2886-4","article-title":"Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery","volume":"42","author":"Cicone","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2026.104859_bib0795","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13550-020-00739-6","article-title":"(18F)-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis","volume":"10","author":"Parent","year":"2020","journal-title":"EJNMMI Res"},{"issue":"5","key":"10.1016\/j.canrad.2026.104859_bib0800","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2967\/jnumed.122.264859","article-title":"Amino acid PET in neurooncology","volume":"64","author":"Galldiks","year":"2023","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.canrad.2026.104859_bib0805","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s41591-025-03633-7","article-title":"RANO criteria for response assessment of brain metastases based on amino acid PET imaging","volume":"31","author":"Albert","year":"2025","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0810","first-page":"6","article-title":"Visual and semi-quantitative analysis of 6-(18F)-FDOPA PET\/CT in patients with brain tumors and suspected tumor recurrence versus radionecrosis","volume":"43","author":"Su\u00e1rez-Pi\u00f1era","year":"2024","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.canrad.2026.104859_bib0815","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13550-024-01158-7","article-title":"A study method using early dynamic acquisition of (18F)-fluorodopa positron emission tomography for the differential diagnosis between progression and radionecrosis of brain metastases after radiotherapy","volume":"14","author":"Barrat","year":"2024","journal-title":"EJNMMI Res"},{"issue":"3","key":"10.1016\/j.canrad.2026.104859_bib0820","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11060-023-04377-5","article-title":"(18F)-fluciclovine PET\/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study","volume":"163","author":"Tom","year":"2023","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.canrad.2026.104859_bib0825","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1007\/s00259-019-04628-6","article-title":"(18F)-fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases","volume":"47","author":"Grkovski","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.canrad.2026.104859_bib0830","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.mri.2012.06.010","article-title":"Radiomics: the process and the challenges","volume":"30","author":"Kumar","year":"2012","journal-title":"Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.canrad.2026.104859_bib0835","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/jmri.24913","article-title":"Support vector machine classification of brain metastasis and radiation necrosis based on texture analysis in MRI","volume":"42","author":"Larroza","year":"2015","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"10.1016\/j.canrad.2026.104859_bib0840","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.ijrobp.2018.05.041","volume":"102","author":"Peng","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0845","first-page":"vdab150","article-title":"Multiparametric radiomic tissue signature and machine learning for distinguishing radiation necrosis from tumor progression after stereotactic radiosurgery","volume":"3","author":"Chen","year":"2021","journal-title":"Neurooncol Adv"},{"issue":"11","key":"10.1016\/j.canrad.2026.104859_bib0850","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/COC.0000000000001036","article-title":"Differentiating radiation necrosis and metastatic progression in brain tumors using radiomics and machine learning","volume":"46","author":"Salari","year":"2023","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2026.104859_bib0855","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s00330-017-5154-8","article-title":"A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images","volume":"28","author":"Zhang","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.canrad.2026.104859_bib0860","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.nicl.2018.08.024","article-title":"Combined FET PET\/MRI radiomics differentiates radiation injury from recurrent brain metastasis","volume":"20","author":"Lohmann","year":"2018","journal-title":"Neuroimage Clin"},{"issue":"2","key":"10.1016\/j.canrad.2026.104859_bib0865","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-024-04669-4","article-title":"Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases","volume":"168","author":"Basree","year":"2024","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104859_bib0870","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11060-024-04697-0","article-title":"Histopathological correlation of brain tumor recurrence vs. radiation effect post-radiosurgery as detected by MRI contrast clearance analysis: a validation study","volume":"168","author":"Goulenko","year":"2024","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.canrad.2026.104859_bib0875","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.canrad.2022.12.002","article-title":"What effective technique to differentiate radiation brain necrosis from a tumor progression in patients treated with radiation: a monocentric retrospective study combining the MRI TRAMs technique and the (18F)-dopa PET\/CT","volume":"27","author":"Lakehayli","year":"2023","journal-title":"Cancer Radiother"},{"issue":"3","key":"10.1016\/j.canrad.2026.104859_bib0880","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/1754-9485.13504","article-title":"Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgery","volume":"67","author":"Admojo","year":"2023","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0885","doi-asserted-by":"crossref","first-page":"E67","DOI":"10.1093\/neuros\/nyaa334","article-title":"A liquid biopsy to assess brain tumor recurrence: presence of circulating Mo-MDSC and CD14+ VNN2+ myeloid cells as biomarkers that distinguish brain metastasis from radiation necrosis following stereotactic radiosurgery","volume":"88","author":"Soler","year":"2021","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.canrad.2026.104859_bib0890","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11060-017-2508-7","article-title":"The ratio of HLA-DR and VNN2+ expression on CD14+ myeloid derived suppressor cells can distinguish glioblastoma from radiation necrosis patients","volume":"134","author":"Soler","year":"2017","journal-title":"J Neurooncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321826000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321826000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:04:00Z","timestamp":1791911040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321826000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1278321826000624"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2026.104859","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential diagnosis of imaging alterations after stereotactic radiotherapy of brain metastases: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2026.104859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104859"}}